{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:05:40Z","timestamp":1754161540167,"version":"3.41.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1023\/b:ddas.0000017453.79349.46","type":"journal-article","created":{"date-parts":[[2004,2,25]],"date-time":"2004-02-25T23:10:23Z","timestamp":1077750623000},"page":"289-294","source":"Crossref","is-referenced-by-count":3,"title":["Natural Interferon \u03b1 Treatment and Interferon \u03b1 Receptor 2 Levels in Acute Hepatitis C"],"prefix":"10.1007","volume":"49","author":[{"given":"Kazuyuki","family":"Ohata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yatsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Daikoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michitami","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"484771_CR1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-2007-1007265","volume":"15","author":"MW Fried","year":"1995","unstructured":"Fried MW, Hoofnagle JH: Therapy of hepatitis C. Semin Liver Dis 15: 82-91, 1995","journal-title":"Semin Liver Dis"},{"key":"484771_CR2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/hep.510260436","volume":"26","author":"PA Bonis","year":"1997","unstructured":"Bonis PA, Ioannidis JP, Cappelleri JC, Kaplan MM, Lau J: Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: A meta-analysis of diagnostic test characteristics. Hepatology 26: 1035-1044, 1997","journal-title":"Hepatology"},{"key":"484771_CR3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, et al.: Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358: 958-965, 2001","journal-title":"Lancet"},{"key":"484771_CR4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/jhep.2001.28706","volume":"34","author":"P Ferenci","year":"2001","unstructured":"Ferenci P, Brunner H, Nachbaur K, et al.: Combination of interferon induction therapy and ribavirin in chronic hepatitis C. Hepatology 34: 1006-1011, 2001","journal-title":"Hepatology"},{"key":"484771_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<217::AID-JMV7>3.0.CO;2-A","volume":"56","author":"E Mizukoshi","year":"1998","unstructured":"Mizukoshi E, Kaneko S, Yanagi M, et al.: Expression of interferon alpha\/beta receptor in the liver of chronic hepatitis C patients. J Med Virol 56: 217-223, 1998","journal-title":"J Med Virol"},{"key":"484771_CR6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0168-8278(99)80252-9","volume":"30","author":"H Yatsuhashi","year":"1999","unstructured":"Yatsuhashi H, Fujino T, Matsumoto T, Inoue O, Koga M, Yano M: Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: Relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol 30: 995-1003, 1999","journal-title":"J Hepatol"},{"key":"484771_CR7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199111073251901","volume":"325","author":"RD Aach","year":"1991","unstructured":"Aach RD, Stevens CE, Hollinger FB, et al.: Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first-and second-generation assays. N Engl J Med 325: 1325-1329, 1991","journal-title":"N Engl J Med"},{"key":"484771_CR8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0016-5085(92)90854-R","volume":"103","author":"JT Wang","year":"1992","unstructured":"Wang JT, Wang TH, Sheu JC, Lin JT, Wang CY, Chen DS: Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Gastroenterology 103: 609-616, 1992","journal-title":"Gastroenterology"},{"key":"484771_CR9","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","volume":"327","author":"MJ Alter","year":"1992","unstructured":"Alter MJ, Margolis HS, Krawczynski K, et al.: The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 327: 1899-1905, 1992","journal-title":"N Engl J Med"},{"key":"484771_CR10","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1046\/j.1440-1746.2000.02112.x","volume":"15","author":"E Tanaka","year":"2000","unstructured":"Tanaka E, Kiyosawa K: Natural history of acute hepatitis C. J Gastroenterol Hepatol 15: E97-E104, 2000","journal-title":"J Gastroenterol Hepatol"},{"key":"484771_CR11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0140-6736(91)91774-O","volume":"338","author":"M Omata","year":"1991","unstructured":"Omata M, Yokosuka O, Takano S, et al.: Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 338: 914-915, 1991","journal-title":"Lancet"},{"key":"484771_CR12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0016-5085(94)90130-9","volume":"107","author":"S Takano","year":"1994","unstructured":"Takano S, Satomura Y, Omata M: Effects of interferon beta on non-A, non-B acute hepatitis: A prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group. Gastroenterology 107: 805-811, 1994","journal-title":"Gastroenterology"},{"key":"484771_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-8278(99)80399-7","volume":"31","author":"W Vogel","year":"1999","unstructured":"Vogel W: Treatment of acute hepatitis C virus infection. J Hepatol 31: 189-192, 1999","journal-title":"J Hepatol"},{"key":"484771_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.1840190105","volume":"19","author":"P Lampertico","year":"1994","unstructured":"Lampertico P, Rumi M, Romeo R, et al.: A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C. Hepatology 19: 19-22, 1994","journal-title":"Hepatology"},{"key":"484771_CR15","first-page":"1041","volume":"86","author":"K Ohnishi","year":"1991","unstructured":"Ohnishi K, Nomura F, Nakano M: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: Response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol 86: 1041-1049, 1991","journal-title":"Am J Gastroenterol"},{"key":"484771_CR16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF01716714","volume":"22","author":"D Palmovic","year":"1994","unstructured":"Palmovic D, Kurelac I, Crnjakovic-Palmovic J: The treatment of acute post-transfusion hepatitis C with recobinant interferon-alpha. Infection 22: 222-223, 1994","journal-title":"Infection"},{"key":"484771_CR17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.1840150504","volume":"15","author":"L Viladomiu","year":"1992","unstructured":"Viladomiu L, Genesca J, Esteban JI, et al.: Interferon-alpha in acute posttransfusion hepatitis C: A randomized, controlled trial. Hepatology 15: 767-769, 1992","journal-title":"Hepatology"},{"key":"484771_CR18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0168-8278(94)80246-7","volume":"21","author":"SJ Hwang","year":"1994","unstructured":"Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ: A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 21: 831-836, 1994","journal-title":"J Hepatol"},{"key":"484771_CR19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/BF02088245","volume":"41","author":"C Camma","year":"1996","unstructured":"Camma C, Almasio P, Craxi A: Interferon as treatment for acute hepatitis C. A meta-analysis. DigDis Sci 41: 1248-1255, 1996","journal-title":"DigDis Sci"},{"key":"484771_CR20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1445-5994.1997.tb00985.x","volume":"27","author":"JW Quin","year":"1997","unstructured":"Quin JW: Interferon therapy for acute hepatitis C viral infection\u2013-A review by meta-analysis. Aust NZ J Med 27: 611-617, discussion 617\u2013618, 1997","journal-title":"Aust NZ J Med"},{"key":"484771_CR21","first-page":"48","volume":"8","author":"T Thevenot","year":"2001","unstructured":"Thevenot T, Regimbeau C, Ratziu V, Leroy V, Opolon P, Poynard T: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update. J Viral Hepatol 8: 48-62, 2001","journal-title":"J Viral Hepatol"},{"key":"484771_CR22","first-page":"181","volume":"30","author":"G Calleri","year":"1998","unstructured":"Calleri G, Colombatto P, Gozzelino M, et al.: Natural beta interferon in acute type-C hepatitis patients: A randomized controlled trial. Ital J Gastroenterol Hepatol 30: 181-184, 1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"484771_CR23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1099\/0022-1317-73-3-673","volume":"73","author":"H Okamoto","year":"1992","unstructured":"Okamoto H, Sugiyama Y, Okada S, et al.: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73: 673-679, 1992","journal-title":"J Gen Virol"},{"key":"484771_CR24","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1099\/0022-1317-74-11-2385","volume":"74","author":"H Okamoto","year":"1993","unstructured":"Okamoto H, Tokita H, Sakamoto M, et al.: Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 74: 2385-2390, 1993","journal-title":"J Gen Virol"},{"key":"484771_CR25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0168-8278(99)80375-4","volume":"31","author":"P Simmonds","year":"1999","unstructured":"Simmonds P: Viral heterogeneity of the hepatitis C viru. J Hepatol 31: 54-60, 1999","journal-title":"J Hepatol"},{"key":"484771_CR26","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S0016-5085(00)70009-6","volume":"118","author":"GL Davis","year":"2000","unstructured":"Davis GL: Current therapy for chronic hepatitis C. Gastroenterology 118: S104-S114, 2000","journal-title":"Gastroenterology"},{"key":"484771_CR27","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","volume":"345","author":"E Jaeckel","year":"2001","unstructured":"Jaeckel E, Cornberg M, Wedemeyer H, et al.: Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345: 1452-1457, 2001","journal-title":"N Engl J Med"},{"key":"484771_CR28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/jhep.2001.22112","volume":"33","author":"JR Orland","year":"2001","unstructured":"Orland JR, Wright TL, Cooper S: Acute hepatitis C. Hepatology 33: 321-327, 2001","journal-title":"Hepatology"},{"key":"484771_CR29","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.1007\/BF02087880","volume":"41","author":"W Vogel","year":"1996","unstructured":"Vogel W, Graziadei I, Umlauft F, et al.: High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study. Dig Dis Sci 41:81S-85S, 1996","journal-title":"Dig Dis Sci"},{"key":"484771_CR30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2893.2001.00268.x","volume":"8","author":"M Gursoy","year":"2001","unstructured":"Gursoy M, Gur G, Arslan H, Ozdemir N, Boyacioglu S: Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment. J Viral Hepatol 8: 70-77, 2001","journal-title":"J Viral Hepatol"},{"key":"484771_CR31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/003655200451270","volume":"35","author":"H Toyoda","year":"2000","unstructured":"Toyoda H, Sakamoto H, Mizuno T, Horiguchi Y, Nakano H: Eradication of hepatitis C virus 1b by interferon in a health care worker with acute hepatitis following needlestick transmission from a patient with chronic hepatitis C unresponsive to interferon. Scand J Gastroenterol 35: 1117-1120, 2000","journal-title":"Scand J Gastroenterol"},{"key":"484771_CR32","first-page":"391","volume":"77","author":"D Novick","year":"1994","unstructured":"Novick D, Cohen B, Rubinstein M: The human interferon alpha\/beta receptor: Characterization and molecular cloning Cell 77: 391-400, 1994","journal-title":"The human interferon alpha\/beta receptor: Characterization and molecular cloning Cell"},{"key":"484771_CR33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1440-1746.1997.tb00467.x","volume":"12","author":"H Yatsuhashi","year":"1997","unstructured":"Yatsuhashi H, Yamasaki K, Aritomi T, et al.: Quantitative analysis of interferon alpha\/beta receptor mRNA in the liver of patients with chronic hepatitis C: Correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon. J Gastroenterol Hepatol 12: 460-467, 1997","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000017453.79349.46.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:DDAS.0000017453.79349.46\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000017453.79349.46.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T02:27:29Z","timestamp":1753756049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:DDAS.0000017453.79349.46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["484771"],"URL":"https:\/\/doi.org\/10.1023\/b:ddas.0000017453.79349.46","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}